Although CMS announced that it would not implement DIR fee reform for 2020, some members of Congress are still attempting to address the issue via the Phair Pricing Act (S. 640).  Certain advocacy groups have made the argument that DIR fee reform may lead to lower costs for patients and provide more pricing transparency for pharmacy owners.  We will continue to follow this story and all developments that impact NCODA stakeholders.